These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
609 related items for PubMed ID: 25443181
1. [A cost-effectiveness study of dexamethasone implants in macular edema]. Lozano López V, Serrano García M, Mantolán Sarmiento C, Pareja Ríos A, Losada Castillo MJ, Cordovés Dorta L, Quijada Fumero E, Virgós Aller T, Bullejos Molina M. Arch Soc Esp Oftalmol; 2015 Jan; 90(1):14-21. PubMed ID: 25443181 [Abstract] [Full Text] [Related]
4. [Tolerability and short-term efficacy of the Ozurdex® dexamethasone intravitreal implant for treatment of uveitic cystoid macular edema: A retrospective study of 52 injections performed at the Clermont-Ferrand teaching hospital]. Bernard Y, Bonnin N, Farguette F, Chiambaretta F. J Fr Ophtalmol; 2016 Jan; 39(1):1-4. PubMed ID: 26616298 [Abstract] [Full Text] [Related]
5. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion. Ding X, Li J, Hu X, Yu S, Pan J, Tang S. Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319 [Abstract] [Full Text] [Related]
6. INTRAVITREAL DEXAMETHASONE IMPLANT FOR THE TREATMENT OF REFRACTORY MACULAR EDEMA IN RETINAL VASCULAR DISEASES: Results of the KKESH International Collaborative Retina Study Group. Alshahrani ST, Dolz-Marco R, Gallego-Pinazo R, Diaz-Llopis M, Arevalo JF, KKESH International Collaborative Retina Study Group. Retina; 2016 Jan; 36(1):131-6. PubMed ID: 26079477 [Abstract] [Full Text] [Related]
7. Intravitreal dexamethasone implant for the treatment of macular edema after retinal vein occlusion in a clinical setting. Ferrini W, Ambresin A. Klin Monbl Augenheilkd; 2013 Apr; 230(4):423-6. PubMed ID: 23629796 [Abstract] [Full Text] [Related]
9. Safety and efficacy of dexamethasone intravitreal implant (Ozurdex) for the treatment of persistent macular edema secondary to retinal vein occlusion in eyes previously treated with anti-vascular endothelial growth factors. Tservakis I, Koutsandrea C, Papaconstantinou D, Paraskevopoulos T, Georgalas I. Curr Drug Saf; 2015 Apr; 10(2):145-51. PubMed ID: 25092480 [Abstract] [Full Text] [Related]
14. Intravitreal triamcinolone for the treatment of macular edema associated with central retinal vein occlusion. Ip MS, Gottlieb JL, Kahana A, Scott IU, Altaweel MM, Blodi BA, Gangnon RE, Puliafito CA. Arch Ophthalmol; 2004 Aug; 122(8):1131-6. PubMed ID: 15302652 [Abstract] [Full Text] [Related]